-+undefined NaN%
-+undefined NaN%
-+undefined NaN%

Morgan Stanley Maintains Equal-Weight on Quest Diagnostics, Raises Price Target to $158

Benzinga · 01/06/2023 10:17
Morgan Stanley analyst Ricky Goldwasser maintains Quest Diagnostics (NYSE:DGX) with a Equal-Weight and raises the price target from $146 to $158.